Moi MK - Search Results

1

Stable bifunctional chelates of metals used in radiotherapy.

Moi MK, DeNardo SJ, Meares CF. Moi MK, et al. Cancer Res. 1990 Feb 1;50(3 Suppl):789s-793s. Cancer Res. 1990. PMID: 2297725

2

Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent.

Deshpande SV, DeNardo SJ, Kukis DL, Moi MK, McCall MJ, DeNardo GL, Meares CF. Deshpande SV, et al. Among authors: moi mk. J Nucl Med. 1990 Apr;31(4):473-9. J Nucl Med. 1990. PMID: 2324823 Free article.

3

Today and tomorrow: radiochemistry for radioimmunotherapy of breast cancer.

DeNardo SJ, Deshpande SV, Moi MK, Adamas GP, McCall MK, DeNardo GL, Meares CF. DeNardo SJ, et al. Among authors: moi mk. Front Radiat Ther Oncol. 1990;24:142-50; discussion 161-5. doi: 10.1159/000417779. Front Radiat Ther Oncol. 1990. PMID: 2341049 No abstract available.

4

Macrocyclic chelates of radiometals for diagnosis and therapy.

Meares CF, Moi MK, Diril H, Kukis DL, McCall MJ, Deshpande SV, DeNardo SJ, Snook D, Epenetos AA. Meares CF, et al. Among authors: moi mk. Br J Cancer Suppl. 1990 Jul;10:21-6. Br J Cancer Suppl. 1990. PMID: 2383477 Free PMC article.

5

Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent.

Moi MK, Meares CF, McCall MJ, Cole WC, DeNardo SJ. Moi MK, et al. Anal Biochem. 1985 Jul;148(1):249-53. doi: 10.1016/0003-2697(85)90653-0. Anal Biochem. 1985. PMID: 4037304

6

Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored mice.

Deshpande SV, DeNardo SJ, Meares CF, McCall MJ, Adams GP, Moi MK, DeNardo GL. Deshpande SV, et al. Among authors: moi mk. J Nucl Med. 1988 Feb;29(2):217-25. J Nucl Med. 1988. PMID: 3258025 Free article.

7

Serum stability of 67Cu chelates: comparison with 111In and 57Co.

Cole WC, DeNardo SJ, Meares CF, McCall MJ, DeNardo GL, Epstein AL, O'Brien HA, Moi MK. Cole WC, et al. Among authors: moi mk. Int J Rad Appl Instrum B. 1986;13(4):363-8. doi: 10.1016/0883-2897(86)90011-5. Int J Rad Appl Instrum B. 1986. PMID: 3539884

8

Comparative serum stability of radiochelates for antibody radiopharmaceuticals.

Cole WC, DeNardo SJ, Meares CF, McCall MJ, DeNardo GL, Epstein AL, O'Brien HA, Moi MK. Cole WC, et al. Among authors: moi mk. J Nucl Med. 1987 Jan;28(1):83-90. J Nucl Med. 1987. PMID: 3794813 Free article.

9

The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid and study of its yttrium(III) complex.

Moi MK, Meares CF, Denardo SJ. Moi MK, et al. J Am Chem Soc. 1988 Aug 1;110(18):6266-7. doi: 10.1021/ja00226a063. J Am Chem Soc. 1988. PMID: 22148823 No abstract available.

10

Formulation and characterization of a ten-peptide single-vial vaccine, EP-2101, designed to induce cytotoxic T-lymphocyte responses for cancer immunotherapy.

Beebe M, Qin M, Moi M, Wu S, Heiati H, Walker L, Newman M, Fikes J, Ishioka GY. Beebe M, et al. Hum Vaccin. 2008 May-Jun;4(3):210-8. doi: 10.4161/hv.4.3.5291. Epub 2010 May 11. Hum Vaccin. 2008. PMID: 18382135

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters